What is Sidoti Csr’s Forecast for Hawkins FY2026 Earnings?

Hawkins, Inc. (NASDAQ:HWKN) – Stock analysts at Sidoti Csr dropped their FY2026 earnings per share estimates for Hawkins in a research note issued on Tuesday, February 3rd. Sidoti Csr analyst D. Harriman now anticipates that the specialty chemicals company will post earnings per share of $4.05 for the year, down from their previous estimate of $4.30. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. Sidoti Csr also issued estimates for Hawkins’ Q4 2026 earnings at $0.83 EPS, Q1 2027 earnings at $1.39 EPS, Q2 2027 earnings at $1.29 EPS, Q3 2027 earnings at $0.92 EPS, Q4 2027 earnings at $1.00 EPS, Q1 2028 earnings at $1.52 EPS and Q2 2028 earnings at $1.43 EPS.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings data on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing the consensus estimate of $0.75 by ($0.03). The business had revenue of $244.08 million for the quarter, compared to analyst estimates of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%.

HWKN has been the topic of several other research reports. BWS Financial restated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research note on Thursday, January 29th. Zacks Research upgraded shares of Hawkins from a “strong sell” rating to a “hold” rating in a research report on Friday, January 2nd. Finally, Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $162.50.

Hawkins Stock Performance

Shares of NASDAQ HWKN opened at $126.72 on Wednesday. Hawkins has a 12 month low of $98.30 and a 12 month high of $186.15. The company has a market cap of $2.65 billion, a P/E ratio of 32.08, a P/E/G ratio of 1.95 and a beta of 0.86. The business’s 50 day moving average is $144.51 and its two-hundred day moving average is $155.71. The company has a quick ratio of 1.46, a current ratio of 2.35 and a debt-to-equity ratio of 0.49.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Salomon & Ludwin LLC acquired a new stake in Hawkins during the third quarter valued at approximately $27,000. First Horizon Corp acquired a new stake in Hawkins in the 3rd quarter valued at $34,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in Hawkins in the second quarter valued at $31,000. Sound Income Strategies LLC acquired a new position in Hawkins during the fourth quarter worth $34,000. Finally, Aster Capital Management DIFC Ltd lifted its holdings in shares of Hawkins by 62.2% during the third quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock valued at $55,000 after acquiring an additional 115 shares during the period. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a $0.19 dividend. The ex-dividend date is Friday, February 13th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Hawkins’s dividend payout ratio is currently 19.24%.

Key Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: WaterSurplus NanoStack pilot completed successfully at Orange County Water District’s GWRS, validating the technology and increasing the odds of commercialization and future revenue from Hawkins’ WaterSurplus subsidiary. This operational milestone is likely driving investor interest in HWKN. Hawkins Announces Milestone for WaterSurplus NanoStack Membranes
• Neutral Sentiment: Recent coverage pieces profile Hawkins as an investment idea and compare it with peers (Novozymes), which can increase investor attention but do not directly change fundamentals. These articles may attract value/sector investors evaluating HWKN against alternatives. NVZMY vs. HWKN: Which Stock Is the Better Value Option?
• Neutral Sentiment: Feature pieces (e.g., Yahoo/InsiderMonkey coverage) outline investment theses for Hawkins and may spur retail/institutional interest; they don’t provide new company-specific financials. What Makes Hawkins (HWKN) an Investment Bet?
• Negative Sentiment: Sidoti Csr cut multiple near-term EPS estimates and trimmed FY2026 guidance: FY2026 EPS was lowered from $4.30 to $4.05 and several quarterly forecasts for 2026–2028 were reduced (notably Q4‑26 to $0.83, Q1‑27 to $1.39, Q2‑27 to $1.29, Q3‑27 to $0.92, Q4‑27 to $1.00, and forward quarters for 2028). These downward revisions suggest Sidoti sees slower near-term earnings growth or margin pressure, which is a negative for sentiment and could cap upside until results show acceleration. Market overview / Sidoti estimates

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.